GPOs实施对美国处方药短缺的影响

• 投稿 • 上一篇

GPOs实施对美国处方药短缺的影响

华娟,路云

中国药科大学国际医药商学院,中国药科大学国际医药商学院

收稿日期:2018-03-09 修回日期:2018-03-09 出版日期:2018-02-25

The Impact of GPOs on the Shortage of Prescription Drugs in the United States

Hua Juan and Lu Yun

School of International Pharmaceutical Business,China Pharmaceutical University,Nanjing,School of International Pharmaceutical Business,China Pharmaceutical University,Nanjing

Received:2018-03-09 Revised:2018-03-09 Online:2018-02-25

摘要/Abstract

摘要： 本文主要采用文献分析方法，分别分析了美国处方药短缺的现状及产生原因，并介绍集团采购组织（GPOs）的运作机制，意在探讨GPOs的实施对美国处方药短缺现状的影响。GPOs的实施对美国处方药供应保障的积极作用表现在提高供应链效率、节约成本、可跟踪药品短缺信息、采用合同订单方式可保障货源稳定供应、分析报告可为医院应对药品短缺风险提供指南方面。对于我国药品供应保障提出一些建议。

Abstract: This article analyzed the status and the causes of the shortage of prescriptions in the United States， and introduced the operating mechanism of group purchase organization（GPOs） by the method of literature analysis.It is intended to explore the impact of the implementation of GPOs on the current shortage of prescriptions in the United States. The active role of GPOs in the protection of the supply of prescriptions in the United States is shown in the following aspects： improving the efficiency of the supply chain， saving costs， keeping track of information on shortage of drugs， and guaranteeing the stable supply of goods by contract orders， providing guidance for hospitals on the risks of drug shortage. Some suggestions are put forward for the guarantee of drug supply in our country.

华娟,路云. GPOs实施对美国处方药短缺的影响[J]. .

Hua Juan and Lu Yun. The Impact of GPOs on the Shortage of Prescription Drugs in the United States[J]. .

参考文献

[1]Department of Health and Human Services Food and Drug Administration, Report to Congress, First Annual Report on Drug Shortages for Calendar Year 2013, [Z]. Required by Section 1002 of the Food and Drug Administration Safety and Innovation Act Public Law, 2014-02-05: 112-144.
[2]FDA.Drug Safety and Availability:Drug Shortges[EB/OL](2011-11-04), http://www.fda.gov/Drugs/DrugSafety/DrugShortages/default.htm.
[3]Six Month Check Up: FDA’s Work on Drug Shortages[EB/OL]2012-05, http://blogs.fda.gov/fdavoice/index.php/2012/05/six-month-check-up-fdas-work-on-drug-shortags/
[4]GAO, Drug Shortages, Public Health Threat Continues, Despite Efforts to Help Ensure Product Availability[R], GAO-14-194 ,2014-2-10 p.27.
[5] Dobson Da Vanzo Associates, A 2014 Update of Cost Savings and Marketplace [EB/OL]2014-6, Analysis of the Health Care Group Purchasing Industry, https://c.ymcdn.com/sites/higpa.site-ym.com/resource/resmgr/research/hsca_cost_savings_group_purc.pdf.
[6]苏涛,常峰,邵蓉.对美国药品集中采购组织的解析[J].上海医药,2011,32(6):295-297.
[7]邵蓉,谢金平,蒋蓉.美国集团采购组织分析及对我国药品采购的启示[J].中国卫生政策研究,2014,7(6):35-40.
[8]侯艳红,丛萌.基于GPO的医疗供应链体系的优化研究[J].工业技术经济,2011,30(05):130-134+155.
[9]Healthcare Supply Chain Association. A Primer on Group Purchasing Organizations[EB/OL]2011-11-2,http://www.supplychainassociation.org/resource/resmgr/research/gpo_primer.pdf.
[10] Group Purchasing Organizations (GPOs) Work to Maintain Access to Product Supply for America’s Health Care Providers [EB/OL]2011. http://c.ymcdn.com/sites/www.supplychainassociation.org/resource/resmgr/research/gpo_drug_shortage_paper.pdf.
[11]黄业姣.社区医院中标药品短缺原因分析及应对措施[J].中国药业,2009,18(18):61-62.
[12]李勇,盛亚楠,赵梦蕊,胡安琪.供应链视角下我国药品短缺原因及供应保障研究[J].卫生经济研究,2017(06):55-59.
[13]张梦倩,冯国忠.美国药品短缺应对机制及其对我国的启示[J].中国药事,2017,31(8):838-842.
[14]尚春成,郭冬梅.国外解决药品短缺的经验及其对我国的启示[J].现代中药研究与实践,2016,30(6):74-78.
[15]常峰,刘洪强.美国集中采购组织实施效果研究及其对我国药品采购的启示[J].中国卫生经济,2015,34(10):93-96.
[16]赵东升,王强,杨凌.ASHP药品短缺管理指南及其对我国的启示[J].中国医药导报,2013,10(17):166-168.
[17]陶立波.发达国家应对药品短缺问题的经验及启示[J].中国卫生政策研究,2008,1(3):38-42.
[18]杨悦,黄果,初智铭,罗玉晶,林琳.美国处理药品短缺问题的经验及其对我国的启示[J].中国药房,2008,19(28):2173-2176.
[19]陈永法,张萍萍,邵蓉.国内外药品招标采购模式比较分析[J].中国执业药师,2013,10(5):37-42.
[20] Roger D B, Durrance C P. Group Purchasing Organizations,monopsony, and antitrust policy[J]. Managerial and Decisioon Economics, 2014,35(3):433-443.
[21] Staff Report, U.S. House of Representatives. FDA’s Contribution to the Drug Shortage Crisis[R]. Washington DC.:Committee on Oversight and Government Reform, 2012.
[22] Hu Q, Schwarz L, Uhan N. The impact of GPOs on health?care-product supply chains[J]. Manufacturing Service Operations Management, 2012,14(1):7-23.
[23] 王强,毛华.集团采购组织在药品采购中的降价机制与发展阶段的经济学分析[J].中国卫生政策研究,2011,4(8):66-70.
[24] 黄柳.深圳药品“团购”顺风起航[J].中国医院院长,2016(13):30-31.

快速检索引用检索图表检索高级检索